EGFR overexpression is correlated with the risk of metastasis, resistance to chemotherapy, and poor survival for patients with breast cancer, some types of melanoma, head and neck squamous cell carcinoma, and non-small cell lung carcinoma [29,30,31]. Here, EGFR is linked to breast carcinoma.